Live Chat ×
Skip to main content

Lobular Neoplasia, In Situ and Invasive

Evaluated by:
David B. Kaminsky, M.D., FIAC, August 8, 2017
Original release date: August 8, 2017
Access to this course expires on: May 5, 2020
CME/SAMs 1.5

Faculty: Sandra Shin, M.D.

Intended Audience:
Practicing academic and community surgical pathologists, pathologists-in-training, and breast pathologists

Learning Objectives:
  • Diagnostically classify lobular neoplasia as classic or variant (i.e., pleomorphic)
  • Recognize histologic features that distinguish ductal carcinoma and in-situ (DCIS) of solid type from lobular carcinoma in-situ (LCIS) variants
  • Integrate adjunctive immunohistochemical studies (e.g., E-cadherin) in the evaluation of lobular neoplasia while recognizing their interpretative nuances and pitfalls

To earn CME and SAM credit, all learners must take a content-based exam and achieve a minimum score of 80%. If learners do not achieve a passing score of 80%, they have the option to retake the exam. After you pass the test and complete the evaluation, your certificate of completion will be available to view and print by clicking here..